We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MREO
426
Mereo BioPharma
MREO
$42.5M
$42.5M $0.2660 6.67%
MCRB icon
427
Seres Therapeutics
MCRB
$42.3M
$42.3M $4.21 8.48%
VERU icon
428
Veru
VERU
$39.6M
$39.6M $2.32 0.85%
KPTI icon
429
Karyopharm Therapeutics
KPTI
$38.6M
$38.6M $1.70 10.4%
ATYR
430
aTyr Pharma
ATYR
$37.7M
$37.7M $0.3841 1.31%
CELU icon
431
Celularity
CELU
$37.3M
$37.3M $1.29 4.03%
EDSA icon
432
Edesa Biotech
EDSA
$37.3M
$37.3M $3.87 6.07%
CRVO icon
433
CervoMed
CRVO
$36.9M
$36.9M $2.44 0.41%
CNTX icon
434
Context Therapeutics
CNTX
$34.8M
$34.8M $0.3790 4.01%
LITS
435
Lite Strategy Inc
LITS
$34.7M
$34.7M $1.02 6.42%
FLNA
436
Filana Therapeutics
FLNA
$33.1M
$33.1M $0.6842 1.77%
ALGS icon
437
Aligos Therapeutics
ALGS
$31.5M
$31.5M $5.05 1.2%
BCTX
438
Briacell Therapeutics
BCTX
$31M
$31M $3.56 0.56%
KYNB
439
Kyntra Bio
KYNB
$30.8M
$30.8M $7.61 2.06%
BYSI icon
440
BeyondSpring
BYSI
$29.1M
$29.1M $0.7088 5.56%
ABVC icon
441
ABVC BioPharma
ABVC
$28.8M
$28.8M $1.08 0.93%
ESLA icon
442
Estrella Immunopharma
ESLA
$27.8M
$27.8M $0.6399 4.73%
QNCX icon
443
Quince Therapeutics
QNCX
$27.6M
$27.6M $27.17 5.82%
NXTC icon
444
NextCure
NXTC
$27.6M
$27.6M $6.03 5.34%
EVAX
445
Evaxion A/S
EVAX
$27.3M
$27.3M $3.03 0.33%
PLRZ
446
Polyrizon Ltd
PLRZ
$25.3M
$25.3M $10.65 6.5%
LTRN icon
447
Lantern Pharma
LTRN
$24.7M
$24.7M $1.93 13.5%
ATOS icon
448
Atossa Therapeutics
ATOS
$24.1M
$24.1M $2.42 2.11%
RADX
449
Radiopharm Theranostics
RADX
$24.1M
$24.1M $1.67 9.87%
ACTU
450
Actuate Therapeutics
ACTU
$24M
$24M $0.9974 1.39%
16 17
18
19 20

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.